Epidemiology, therapy and outcome of hepatocellular carcinoma between 2010 and 2019 in Piedmont, Italy

doi:10.4251/wjgo.v16.i3.761

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1979)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

WORD

HTML

1248

Figures (1-4)

112

Tables (1-3)

111

Sum=1500

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

352

Sum=436

Mar 15, 2024 (publication date) through Aug 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Oncol. Mar 15, 2024; 16(3): 761-772
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.761

Table 1 General characteristics

Characteristics	2010-2014, 154 patients	2015-2019, 174 patients	All patients, 328
Sex, n (%)
Male	122 (79)	133 (76)	255 (78)
Female	32 (21)	41 (24)	73 (22)
Age in yr, mean ± SD
At diagnosis	67.6 ± 11.8	70 ± 10.7	68.9 ± 11.3
At death	69.7 ± 12.2^a	72.4 ± 10.5^a	71 ± 11.4
Etiology, n (%)
HCV	65 (42)	70 (40)	135 (41)
HBV	10 (6)	5 (3)	15 (5)
Alcoholic	18 (12)	40 (23)	58 (18)
Multiple etiology¹	16 (10)	20 (11)	36 (11)
NAFLD	5 (3)	2 (1)	7 (2)
Hereditary hemochromatosis	0 (0)	4 (2)	4 (1)
Unknown/idiopathic	40 (26)	33 (19)	73 (22)

^aP < 0.05.

¹Viral and alcoholic. HBV: Hepatitis B virus; HCV: Hepatitis C virus; NAFLD: Nonalcoholic fatty liver disease; SD: Standard deviation.

Citation: Bracco C, Gallarate M, Badinella Martini M, Magnino C, D'Agnano S, Canta R, Racca G, Melchio R, Serraino C, Polla Mattiot V, Gollè G, Fenoglio L. Epidemiology, therapy and outcome of hepatocellular carcinoma between 2010 and 2019 in Piedmont, Italy. World J Gastrointest Oncol 2024; 16(3): 761-772
URL: https://www.wjgnet.com/1948-5204/full/v16/i3/761.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i3.761